Skip to main content
OpenTrials

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,254 public trials 565 recruiting studies
Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Recruiting

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

NCT05797168

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +27 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Aurora, Colorado, United States
View all 60 locations
View Trial Details
Recruiting

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NCT07524322

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Houston Houston, Texas, United States
  • NEXT San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 52 locations
View Trial Details
Recruiting

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

NCT07306559

Conditions
Adnexal Diseases, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Germ Cell Tumours, +18 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Indiana University Indianapolis, Indiana, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 13 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details
Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

NCT04291612

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Miami Cancer Institute Baptist Health South Florida Miami, Florida, United States
  • ADVENTHEALTH (Data collection only) Orlando, Florida, United States
  • Mayo Clinic (Data Collection and Data Analysis) Rochester, Minnesota, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

NCT06340568

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Broward Health Medical Center Fort Lauderdale, Florida, United States
  • OSF Saint Francis Medical Center Peoria, Illinois, United States
View all 171 locations
View Trial Details

Related conditions